Analysis of endocannabinoids in plasma samples by biocompatible solid-phase microextraction devices coupled to mass spectrometry
- 1 December 2019
- journal article
- research article
- Published by Elsevier in Analytica Chimica Acta
- Vol. 1091, 135-145
Abstract
No abstract availableKeywords
Funding Information
- Natural Sciences and Engineering Research Council of Canada
- Fundação de Amparo à Pesquisa do Estado de São Paulo (2016/16180-6, 2017/02147-0)
This publication has 62 references indexed in Scilit:
- Plasma Concentrations of Endocannabinoids and Related Primary Fatty Acid Amides in Patients with Post-Traumatic Stress DisorderPLOS ONE, 2013
- Recent trends in SPME concerning sorbent materials, configurations and in vivo applicationsTrAC Trends in Analytical Chemistry, 2013
- Quantitative analysis of multiple fatty acid ethanolamides using ultra-performance liquid chromatography–tandem mass spectrometryProstaglandins, Leukotrienes and Essential Fatty Acids, 2012
- Cannabidiol enhances anandamide signaling and alleviates psychotic symptoms of schizophreniaTranslational Psychiatry, 2012
- Molecular reorganization of endocannabinoid signalling in Alzheimer’s diseaseBrain, 2011
- An overview of matrix effects in liquid chromatography–mass spectrometryMass Spectrometry Reviews, 2010
- Enhanced Anandamide Plasma Levels in Patients with Complex Regional Pain Syndrome following Traumatic Injury: A Preliminary ReportEuropean Surgical Research, 2009
- Endocannabinoids and the regulation of their levels in health and diseaseCurrent Opinion in Lipidology, 2007
- Very late onset in ataxia oculomotor apraxia type IAnnals of Neurology, 2005
- High endogenous cannabinoid levels in the cerebrospinal fluid of untreated Parkinson's disease patientsAnnals of Neurology, 2005